Evidence map›Paper›PMID 24764294›Full record

ArticleThe Journal of biological chemistry2014

Endothelial nitric-oxide synthase (eNOS) is activated through G-protein-coupled receptor kinase-interacting protein 1 (GIT1) tyrosine phosphorylation and Src protein.

Songling Liu, Richard T Premont, Don C Rockey

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Association ofIranian journal of basic medical sciences · 2021
    Article
  8. Review
  9. Article
  10. β-Arrestin2 is a critical component of the GPCR-eNOS signalosome.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  11. Lung Endothelial Transcytosis.Comprehensive Physiology · 2020
    Review
  12. Anti-apoptotic activity of ETScientific reports · 2019
    Article
  13. Review
  14. Deletion of T-type calcium channels CaPflugers Archiv : European journal of physiology · 2018
    Article
  15. Biology of portal hypertension.Hepatology international · 2018
    Review
  16. Nitric oxide: what's new to NO?American journal of physiology. Cell physiology · 2017
    Review
  17. The Molecular Basis of Portal Hypertension.Transactions of the American Clinical and Climatological Association · 2017
    Review
  18. The eNOS signalosome and its link to endothelial dysfunction.Pflugers Archiv : European journal of physiology · 2016
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Songling LiuFrom the Department of Medicine, Medical University of South Carolina, Charleston, South Carolina 29425 and.
Richard T PremontDepartment of Medicine, Duke University Medical Center, Durham, North Carolina 27710.
Don C RockeyFrom the Department of Medicine, Medical University of South Carolina, Charleston, South Carolina 29425 and rockey@musc.edu.
Duke Medical Center · US

Funding

NO AND THE CELLULAR PATHOGENESIS OF PORTAL HYPERTENSIONR01DK057830 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI ROCKEY, DON C. · 2000 to 2012
$2.6M
NIDDK NIH HHS R01 DK057830NIDDK NIH HHS R01 DK 57830
6 · The paper itself

Abstract

Nitric oxide (NO) is a critical regulator of vascular tone and plays an especially prominent role in liver by controlling portal blood flow and pressure within liver sinusoids. Synthesis of NO in sinusoidal endothelial cells by endothelial nitric-oxide synthase (eNOS) is regulated in response to activation of endothelial cells by vasoactive signals such as endothelins. The endothelin B (ETB) receptor is a G-protein-coupled receptor, but the mechanisms by which it regulates eNOS activity in sinusoidal endothelial cells are not well understood. In this study, we built on two previous strands of work, the first showing that G-protein βγ subunits mediated activation of phosphatidylinositol 3-kinase and Akt to regulate eNOS and the second showing that eNOS directly bound to the G-protein-coupled receptor kinase-interacting protein 1 (GIT1) scaffold protein, and this association stimulated NO production. Here we investigated the mechanisms by which the GIT1-eNOS complex is formed and regulated. GIT1 was phosphorylated on tyrosine by Src, and Y293F and Y554F mutations reduced GIT1 phosphorylation as well as the ability of GIT1 to bind to and activate eNOS. Akt phosphorylation activated eNOS (at Ser(1177)), and Akt also regulated the ability of Src to phosphorylate GIT1 as well as GIT1-eNOS association. These pathways were activated by endothelin-1 through the ETB receptor; inhibiting receptor-activated G-protein βγ subunits blocked activation of Akt, GIT1 tyrosine phosphorylation, and ET-1-stimulated GIT1-eNOS association but did not affect Src activation. These data suggest a model in which Src and Akt cooperate to regulate association of eNOS with the GIT1 scaffold to facilitate NO production.

Indexed as

Amino Acid MotifsAnimalsCell Cycle ProteinsEndothelial CellsEnzyme ActivationHumansMaleNitric OxideNitric Oxide Synthase Type IIIPhosphatidylinositol 3-KinasesPhosphoproteinsPhosphorylationProtein BindingProto-Oncogene Proteins c-aktProto-Oncogene Proteins pp60(c-src)RatsCell Cycle ProteinsGit1 protein, ratNitric OxideNitric Oxide Synthase Type IIIPhosphatidylinositol 3-KinasesPhosphoproteinsProto-Oncogene Proteins c-aktProto-Oncogene Proteins pp60(c-src)TyrosineEndothelial CellEndothelial DysfunctionEndothelinG-proteinNitric OxideNitric-oxide Synthase

Identifiers

PMID24764294
PMCPMC4140289
OpenAlexW1974996125

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.